Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6137)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2013 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Meer SV, Man RA, Siersema PD, Erpecum KJV. Surveillance for hepatocellular carcinoma in chronic liver disease: Evidence and controversies. World J Gastroenterol 2013; 19(40): 6744-6756 [PMID: 24187450 DOI: 10.3748/wjg.v19.i40.6744] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i40/6744.htm |
| Number | Citing Articles |
| 1 |
Peiwan Jia, Ruirong Liu, Yun Liu, Yanyan Wu, Ting Dou, Yuvaraja Teekaraman. Comparison of the Value of Color Doppler Ultrasound and Multislice Spiral CT in the Differential Diagnosis of Benign and Malignant Nodules in the Liver. Contrast Media & Molecular Imaging 2022; 2022: 1 doi: 10.1155/2022/5251966
|
| 2 |
Michael J. Reiter, Justin E. Costello, Ryan B. Schwope, Christopher J. Lisanti, Michael B. Osswald. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation. Journal of Computer Assisted Tomography 2015; 39(6): 825 doi: 10.1097/RCT.0000000000000297
|
| 3 |
Kunihiro Hasegawa, Ryo Takata, Hiroki Nishikawa, Hirayuki Enomoto, Akio Ishii, Yoshinori Iwata, Yuho Miyamoto, Noriko Ishii, Yukihisa Yuri, Chikage Nakano, Takashi Nishimura, Kazunori Yoh, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi. Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis. International Journal of Molecular Sciences 2016; 17(9): 1500 doi: 10.3390/ijms17091500
|
| 4 |
A. Kornberg. Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/706945
|
| 5 |
Peng Li, Huiguo Ding. Stratified screening of hepatocellular carcinoma in high-risk populations. Radiology of Infectious Diseases 2015; 2(2): 109 doi: 10.1016/j.jrid.2015.07.002
|
| 6 |
Talita Duarte-Salles, Sandeep Misra, Magdalena Stepien, Amelie Plymoth, David Muller, Kim Overvad, Anja Olsen, Anne Tjønneland, Laura Baglietto, Gianluca Severi, Marie-Christine Boutron-Ruault, Renee Turzanski-Fortner, Rudolf Kaaks, Heiner Boeing, Krasimira Aleksandrova, Antonia Trichopoulou, Pagona Lagiou, Christina Bamia, Valeria Pala, Domenico Palli, Amalia Mattiello, Rosario Tumino, Alessio Naccarati, H.B(as). Bueno-de-Mesquita, Petra H. Peeters, Elisabete Weiderpass, J. Ramón Quirós, Antonio Agudo, Emilio Sánchez-Cantalejo, Eva Ardanaz, Diana Gavrila, Miren Dorronsoro, Mårten Werner, Oskar Hemmingsson, Bodil Ohlsson, Klas Sjöberg, Nicholas J. Wareham, Kay-Tee Khaw, Kathryn E. Bradbury, Marc J. Gunter, Amanda J. Cross, Elio Riboli, Mazda Jenab, Pierre Hainaut, Laura Beretta. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population. Cancer Prevention Research 2016; 9(9): 758 doi: 10.1158/1940-6207.CAPR-15-0434
|
| 7 |
Peiwan Jia, Yunjie Mao, Kahua Liu, XianJuan Wei, Suneet Kumar Gupta. The Value of Color Doppler Ultrasound and CT Combined with Serum AFP Examination in the Diagnosis of Hepatocellular Carcinoma. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/4147753
|
| 8 |
Hiroki Nishikawa, Kunihiro Hasegawa, Akio Ishii, Ryo Takata, Hirayuki Enomoto, Kazunori Yoh, Kyohei Kishino, Yoshihiro Shimono, Yoshinori Iwata, Chikage Nakano, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi. A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation. Medicine 2016; 95(35): e4679 doi: 10.1097/MD.0000000000004679
|
| 9 |
GUIHONG HUANG, BO TANG, KUN TANG, XIAOMIN DONG, JUNGANG DENG, LUQIN LIAO, ZENGZHEN LIAO, HUA YANG, SONGQING HE. Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway. Oncology Reports 2014; 31(5): 2377 doi: 10.3892/or.2014.3099
|
| 10 |
Yan Wang, Lei Dong, Jing Li, Miaosha Luo, Boxin Shang. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling. Life Sciences 2017; 183: 60 doi: 10.1016/j.lfs.2017.05.029
|
| 11 |
Maryam Ranjpour, Saima Wajid, Swatantra Kumar Jain. Elevated expression of sepiapterin reductase, regulator of G protein signaling 1, hypothetical protein CXorf58 homolog, and zinc finger and BTB domain–containing protein 21 isoform X2 is associated with progression of hepatocellular carcinoma. Protoplasma 2021; 258(5): 1133 doi: 10.1007/s00709-021-01632-2
|
| 12 |
Yukio Osaki, Hiroki Nishikawa. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review. Hepatology Research 2015; 45(1): 59 doi: 10.1111/hepr.12378
|
| 13 |
Danijel Galun, Dragan Basaric, Marinko Zuvela, Predrag Bulajic, Aleksandar Bogdanovic, Nemanja Bidzic, Miroslav Milicevic. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World Journal of Hepatology 2015; 7(20): 2274-2291 doi: 10.4254/wjh.v7.i20.2274
|
| 14 |
Jun Li, Chenjie Qin, Yicheng Wu, Sheng Cheng, Yuanqing Wang, Huijie Chen, Fangli Chen, Bingdi Chen, Jutang Li. Targeting LRRC41 as a potential therapeutic approach for hepatocellular carcinoma. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1300294
|
| 15 |
María Sarai González Huezo, Juan Francisco Sánchez Ávila. Mexican consensus on the diagnosis and management of hepatocellular carcinoma. Revista de Gastroenterología de México (English Edition) 2014; 79(4): 250 doi: 10.1016/j.rgmxen.2014.12.002
|
| 16 |
Teerapat Ungtrakul, Chulabhorn Mahidol, Pattra Chun-on, Charlie Laohapand, Surachate Siripongsakun, Akeanong Worakitsitisatorn, Sirachat Vidhayakorn, Wariya Boonchuay, Jiraporn Dechma, Gaidganok Sornsamdang, Kamonwan Soonklang, Tassanee Sriprayoon, Tawesak Tanwandee, Chirayu U Auewarakul. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. World Journal of Gastroenterology 2016; 22(34): 7806-7812 doi: 10.3748/wjg.v22.i34.7806
|
| 17 |
Yueran Zhuo, Qiushi Chen, Jagpreet Chhatwal. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 53 doi: 10.1007/978-3-030-21540-8_3
|
| 18 |
Jorge Marrero, Mary A. Maluccio, Heather Mccurdy, Ghassan K. Abou-Alfa. Expert Perspectives on Evidence-Based Treatment Planning for Patients with Hepatocellular Carcinoma. Cancer Control 2014; 21(2_suppl): 5 doi: 10.1177/1073274814021002s02
|
| 19 |
Jian-Xiang Niu, Xing-Kai Meng, Jian-Jun Ren. Studied microRNA gene expression in human hepatocellular carcinoma by microRNA microarray techniques. World Journal of Gastroenterology 2015; 21(44): 12605-12611 doi: 10.3748/wjg.v21.i44.12605
|
| 20 |
François Willemssen, Quido de Lussanet de la Sablonière, Daniel Bos, Jan IJzermans, Robert De Man, Roy Dwarkasing. Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC. Cancers 2022; 14(16): 3961 doi: 10.3390/cancers14163961
|
| 21 |
Hao Qin, Baowen Yuan, Wei Huang, Yan Wang. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.924696
|
| 22 |
Y.B. Esterson, M. Flusberg, S. Oh, F. Mazzariol, A.M. Rozenblit, V. Chernyak. Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors. Clinical Radiology 2015; 70(7): 723 doi: 10.1016/j.crad.2015.03.005
|
| 23 |
Salem Youssef Mohamed, Ahmed Elsayed Esmaiel, Marwa Abo Shabana, Nevin Fouad Ibrahim. Assessment of Plasma Vitronectin as Diagnostic and Prognostic Marker of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Cirrhosis. Gastroenterology Insights 2022; 13(1): 9 doi: 10.3390/gastroent13010002
|
| 24 |
Dennie GA Hebels, Marlon JA Jetten, Hugo JW Aerts, Ralf Herwig, Daniël HJ Theunissen, Stan Gaj, Joost H van Delft, Jos CS Kleinjans. Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity. Biomarkers in Medicine 2014; 8(2): 185 doi: 10.2217/bmm.13.154
|
| 25 |
Qingyuan Zheng, Qiyao Zhang, Xiao Yu, Yuting He, Wenzhi Guo. FENDRR: A pivotal, cancer-related, long non-coding RNA. Biomedicine & Pharmacotherapy 2021; 137: 111390 doi: 10.1016/j.biopha.2021.111390
|
| 26 |
María Sarai González Huezo, Juan Francisco Sánchez Ávila. Consenso mexicano de diagnóstico y manejo del carcinoma hepatocelular. Revista de Gastroenterología de México 2014; 79(4): 250 doi: 10.1016/j.rgmx.2014.09.004
|
| 27 |
Sandra Coenen, Suzanne van Meer, Jan M. Vrolijk, Clemens Richter, Karel J. van Erpecum, Marijke C. Mostert, Irene K. Veldhuijzen, Jurriën G. P. Reijnders, Hanneke van Soest, Kees Dirksen, Joost P. H. Drenth, René P. M. Koene, Maaike Bosschart, Pieter Friederich, Martijn J. ter Borg, Rick H. P. J. Daemen, Joop E. Arends, Marc A. M. T. Verhagen, Christine Schout, B. W. Marcel Spanier. Clinical impact of five large‐scale screening projects for chronic hepatitis B in Chinese migrants in the Netherlands. Liver International 2016; 36(10): 1425 doi: 10.1111/liv.13125
|
| 28 |
Suzanne van Meer, Robert A de Man, Aad P van den Berg, Roderick H J Houwen, Francisca H H Linn, Martijn G H van Oijen, Peter D Siersema, Karel J van Erpecum. No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long‐term follow‐up. Journal of Gastroenterology and Hepatology 2015; 30(3): 535 doi: 10.1111/jgh.12716
|
| 29 |
Mojca Maticic, Jerneja Videcnik Zorman, Sergeja Gregorcic, Eberhard Schatz, Jeffrey V Lazarus. Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries. BMC Infectious Diseases 2014; 14(S6) doi: 10.1186/1471-2334-14-S6-S14
|
| 30 |
Andrew J. Muir. Understanding the Complexities of Cirrhosis. Clinical Therapeutics 2015; 37(8): 1822 doi: 10.1016/j.clinthera.2015.05.507
|
| 31 |
Hiroki Nishikawa, Ryo Takata, Hirayuki Enomoto, Kazunori Yoh, Kyohei Kishino, Yoshihiro Shimono, Yoshinori Iwata, Kunihiro Hasegawa, Chikage Nakano, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Akio Ishii, Hiroko Iijima, Shuhei Nishiguchi. Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein in chronic hepatitis C. Hepatology Research 2017; 47(3) doi: 10.1111/hepr.12724
|
| 32 |
Suzanne Sheppard‐Law, Iryna Zablotska‐Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Jacob George, Amany Zekry, Lisa Maher. Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus‐related carcinoma and prescribed anti‐viral therapy. Journal of Clinical Nursing 2018; 27(13-14): 2673 doi: 10.1111/jocn.14367
|
| 33 |
|
| 34 |
Ilvira M. Khan, Donjeta Gjuka, Jingjing Jiao, Xiaoling Song, Ying Wang, Jing Wang, Peng Wei, Hashem B. El-Serag, Jorge A. Marrero, Laura Beretta. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prevention Research 2021; 14(6): 667 doi: 10.1158/1940-6207.CAPR-20-0600
|
| 35 |
Albina Nowak, Rebekka S. Giger, Pierre-Alexandre Krayenbuehl. Higher age at diagnosis of hemochromatosis is the strongest predictor of the occurrence of hepatocellular carcinoma in the Swiss hemochromatosis cohort. Medicine 2018; 97(42): e12886 doi: 10.1097/MD.0000000000012886
|
| 36 |
Yoshikuni Inokawa, Kenichi Inaoka, Fuminori Sonohara, Masamichi Hayashi, Mitsuro Kanda, Shuji Nomoto. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncology Letters 2016; 12(5): 3662 doi: 10.3892/ol.2016.5141
|
| 37 |
N. Semmo, T. Weber, J. R. Idle, D. Beyoğlu. Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection. Journal of Viral Hepatitis 2015; 22(7): 617 doi: 10.1111/jvh.12376
|
| 38 |
Nowlan Selvapatt, Henry House, Ashley Brown. Hepatocellular Carcinoma Surveillance. Journal of Clinical Gastroenterology 2016; 50(1): e8 doi: 10.1097/MCG.0000000000000344
|